Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 15.60 INR
Change Today -0.70 / -4.29%
Volume 25.4K
ALPA On Other Exchanges
Symbol
Exchange
Natl India
As of 7:33 AM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

alpa laboratories ltd (ALPA) Snapshot

Open
15.65
Previous Close
16.30
Day High
15.85
Day Low
15.50
52 Week High
10/31/14 - 21.70
52 Week Low
05/16/14 - 7.70
Market Cap
328.2M
Average Volume 10 Days
37.8K
EPS TTM
-2.45
Shares Outstanding
21.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ALPA LABORATORIES LTD (ALPA)

Related News

No related news articles were found.

alpa laboratories ltd (ALPA) Related Businessweek News

No Related Businessweek News Found

alpa laboratories ltd (ALPA) Details

Alpa Laboratories Limited manufactures and markets pharmaceutical finished dosage forms to various pharmaceutical companies primarily in India. The company offers its products formulations in various finished dosage forms, including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions for veterinary use. It provides products in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoans, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular products; anti-diabetics; nutritional supplements; psychotropic drugs; skin care preparations; and ear and eye care preparations. Alpa Laboratories Limited sells its products through distributors, as well as retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to various countries in South and Central America, Africa, and Asia, including CIS countries comprising Russia, Ukraine, Kazakhstan, etc. Alpa Laboratories Limited was incorporated in 1988 and is based in Indore, India.

Founded in 1988

alpa laboratories ltd (ALPA) Top Compensated Officers

Executive Chairman, Managing Director, Member...
Total Annual Compensation: 2.7M
Whole Time Director and Member of Shareholder...
Total Annual Compensation: 2.7M
Whole Time Director
Total Annual Compensation: 2.5M
Compensation as of Fiscal Year 2014.

alpa laboratories ltd (ALPA) Key Developments

Alpa Laboratories Appoints Shashi Jain as Director

Alpa Laboratories announced that Shashi Jain has been appointed as a Director of the Company with effect from March 31, 2015 for a period of 5 years by the Board of Directors of the Company.

Alpa Laboratories Ltd Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Alpa Laboratories Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales/income from operations was INR 135.252 million against INR 143.772 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 15.29 million against INR 3.404 million a year ago. Profit from ordinary activities before tax was INR 26.321 million compared to INR 0.361 million for the same period a year ago. Net loss after tax was INR 15.415 million or INR 0.73 basic and diluted loss per share against INR 0.639 million or INR 0.03 basic and diluted loss per share a year ago. For the nine months, the company reported net sales/income from operations was INR 419.484 million against INR 368.17 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 8.795 million against INR 33.39 million a year ago. Loss from ordinary activities before tax was INR 7.896 million compared to INR 38.597 million for the same period a year ago. Net loss after tax was INR 49.632 million or INR 2.36 basic and diluted loss per share against INR 40.077 million or INR 1.90 basic and diluted loss per share a year ago.

Alpa Laboratories Ltd, Board Meeting, Feb 11, 2015

Alpa Laboratories Ltd, Board Meeting, Feb 11, 2015. Agenda: To consider and approve the financial results for the quarter and period ended December 31, 2014 along with other routine business.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALPA:IN 15.60 INR -0.70

ALPA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALPA.
View Industry Companies
 

Industry Analysis

ALPA

Industry Average

Valuation ALPA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book 0.4x
Price/Cash Flow 95.6x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALPA LABORATORIES LTD, please visit www.alpalabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.